science
plus
.abes.fr
|
explorer
À propos de :
Biological agents
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
skos:Concept
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Concept
New Facet based on Instances of this Class
Attributs
Valeurs
type
Concept
rdfs:label
Biological agents
skos:inScheme
http://hub.abes.fr/referentiel/hwpjournalcoll
is
Subject
of
Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics
Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial
Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis
Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis
A prospective study of renal disease in patients with early rheumatoid arthritis
Reporting of outcomes in arthritis trials measured on ordinal and interval scales is inadequate in relation to meta-analysis
Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
Today's Drugs
Critique of Freud
Comparison of 12 different containers for dispensing anti-inflammatory drugs.
Regular Review: Interferon for treatment: the dust settles
Searching for gastrinomas.
Innovation in the pharmaceutical industry
ABC of Rheumatology: FIBROMYALGIA SYNDROME
Author's reply
Confusion over use of placebos in clinical trials
Many chronic pain control treatments are ineffective
Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy
Antidepressants and upper gastrointestinal bleeding
Injection with methylprednisolone for carpal tunnel syndrome
BAX gene needed for NSAIDs chemoprotection
Steroid injections are helpful in rotator cuff tendinopathy
Potential alternatives to COX 2 inhibitors
Aspirin shown to reduce risk of pancreatic cancer
Antibiotics can improve outcomes in heart patients
India admits to unapproved drug formulations in market
Celecoxib, rofecoxib, and acute temporary visual impairment
Danish group reanalyses miscarriage in NSAID users
Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs
Merck chief quits as further material on Vioxx emerges
Why should preterm births be rising?
Chondroitin sulphate may help knee osteoarthritis a little
Patients with suspected rheumatoid arthritis should be referred early to rheumatology
Postoperative problems
C reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab
Systemic juvenile idiopathic arthritis presenting in a young child with long term disability as an adolescent
Non-surgical treatment of osteoarthritis: a half century of “advances”
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects
Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra
Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
Undiagnosed abdominal pain.
Psychiatry in the general hospital.
Epididymo-orchitis.
Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2.
The psychiatry of HIV infection.
Aspirin and bleeding peptic ulcers in the elderly.
Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.
The gene for von Hippel-Lindau disease.
Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhoea
GPs' management of acute back pain
Recent advances: Rheumatology
Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care
Risk of ulcer soars with combination of arthritis drugs
Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study
Preventing stroke
Tales of discovery, obfuscation, error, and improvement
US report blames poor quality control for soaring healthcare costs
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
Managing acute renal colic
Number reacting to smallpox vaccination is higher than expected
Topical NSAIDs in osteoarthritis
Placebos in medicine
English trusts fail to follow guidance on infection control
Bird flu's deadly effects may give clues to treatment
Diagnosis and management of ankylosing spondylitis
What have we learnt from Vioxx?
Newly diagnosed iron deficiency anaemia in a premenopausal woman
Sumatriptan-naproxen works well for migraine
Aspirin reduced risk of cancer in large US study
Interpreting the rights in the NHS constitution
Osteoarthritis and protection from global functional decline
Intestinal complications of Behçet’s disease
EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)
Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions
Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
Methotrexate modulates the kinetics of adenosine in humans in vivo
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Anti-TNFα: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study
Hypercalciuria in sarcoidosis treated with inorganic phosphates.
Epidemiology for the uninitiated. Repeatability and validity.
Heparin and infusion phlebitis.
Avascular necrosis of bone caused by combination chemotherapy without corticosteroids.
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 9
Go
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata